Jennison Associates LLC Cyma Bay Therapeutics, Inc. Transaction History

Jennison Associates LLC

  • $160 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024
BUY
$12.63 - $24.47 $5.52 Million - $10.7 Million
437,437 Added 12.3%
3,992,711 $94.3 Million
Q3 2023

Oct 31, 2023
BUY
$10.86 - $17.62 $20.5 Million - $33.2 Million
1,883,742 Added 112.7%
3,555,274 $53 Million
Q2 2023

Aug 03, 2023
BUY
$7.47 - $10.95 $7.83 Million - $11.5 Million
1,047,869 Added 168.02%
1,671,532 $18.3 Million
Q1 2023

Apr 26, 2023
BUY
$5.88 - $9.59 $3.67 Million - $5.98 Million
623,663 New
623,663 $5.44 Million

Others Institutions Holding CBAY

# of Institutions
6
Shares Held
1.82M
Call Options Held
0
Put Options Held
0
View Full List

About CymaBay Therapeutics, Inc.

CBAY Quotes by TradingView
  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email